Literature DB >> 1170830

A lipid inhibitor of dengue virus in human colostrum and milk; with a note on the absence of anti-dengue secretory antibody.

W A Falkler, A R Diwan, S B Halstead.   

Abstract

Neutralizing activity against dengue virus types 1--4 was observed in milk samples from 5 non-immune and 29 dengue immune women. Anti-dengue activity in milk and colostrum was found only in the lipid component. The inhibitory activity is directed against the virus and not cell surfaces. When immunoglobulin types IgM,IgA, IgG were isolated from colostrum from dengue immune women, no antibody activity was found. Anti-dengue activity in human milk did not decrease over a period of ten months after delivery.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1170830     DOI： 10.1007/bf01315587

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  10 in total

1.  Relationships between arthropod-borne viruses based on antigenic analysis, growth requirements, and selective biochemical inactivation.

Authors:  A B SABIN
Journal:  Ann N Y Acad Sci       Date:  1953-03-31       Impact factor: 5.691

2.  [Antibodies to the Lansing strain of poliomyelitis virus in sera and colostra in Hungary].

Authors:  M PINTER
Journal:  Acta Med Acad Sci Hung       Date:  1953

3.  Antipoliomyelitic activity of human and bovine colostrum and milk.

Authors:  A B SABIN; A H FIELDSTEEL
Journal:  Pediatrics       Date:  1962-01       Impact factor: 7.124

4.  Paralytic consequences of poliomyelitis infection in different parts of the world and in different population groups.

Authors:  A B SABIN
Journal:  Am J Public Health Nations Health       Date:  1951-10

5.  Antipoliomyelitic substance in milk of human beings and certain cows.

Authors:  A B SABIN
Journal:  AMA Am J Dis Child       Date:  1950-11

6.  Anti-dengue immunoglobulins and serum beta 1 c-a globulin levels in dengue shock syndrome.

Authors:  P K Russell; A Intavivat; S Kanchanapilant
Journal:  J Immunol       Date:  1969-02       Impact factor: 5.422

7.  The antimicrobial activity of human colostral antibody in the newborn.

Authors:  J G Michael; R Ringenback; S Hottenstein
Journal:  J Infect Dis       Date:  1971-11       Impact factor: 5.226

8.  Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections.

Authors:  N J Marchette; S B Halstead; W A Falkler; A Stenhouse; D Nash
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

9.  Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host.

Authors:  S B Halstead; P Simasthien
Journal:  Yale J Biol Med       Date:  1970-04

10.  Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses.

Authors:  S B Halstead; S Udomsakdi; P Simasthien; P Singharaj; P Sukhavachana; A Nisalak
Journal:  Yale J Biol Med       Date:  1970-04
  10 in total
  10 in total

1.  Editorial: Breast-feeding: the immunological argument.

Authors: 
Journal:  Br Med J       Date:  1976-05-15

2.  Colostrum as a source of togavirus inhibitors.

Authors:  K F Shortridge
Journal:  Arch Dis Child       Date:  1977-02       Impact factor: 3.791

3.  Size and stability of a naturally occurring virus inhibitor.

Authors:  D H Coppenhaver; J L Baron; M L McKerlie; J Sabados; S Baron
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

4.  Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides.

Authors:  H Thormar; C E Isaacs; H R Brown; M R Barshatzky; T Pessolano
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

5.  Infant formulas and gastrointestinal illness.

Authors:  J S Koopman; V J Turkish; A S Monto
Journal:  Am J Public Health       Date:  1985-05       Impact factor: 9.308

6.  Milk fat and gastrointestinal illness.

Authors:  J S Koopman; V J Turkisk; A S Monto; F E Thompson; R E Isaacson
Journal:  Am J Public Health       Date:  1984-12       Impact factor: 9.308

7.  Use of Semliki forest virus to identify lipid-mediated antiviral activity and anti-alphavirus immunoglobulin A in human milk.

Authors:  J K Welsh; I J Skurrie; J T May
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

8.  Detection of Zika virus in mouse mammary gland and breast milk.

Authors:  Jose Angel Regla-Nava; Karla M Viramontes; Teodora Vozdolska; Anh-Thy Huynh; Tom Villani; Graeme Gardner; Michael Johnson; Pamela J Ferro; Sujan Shresta; Kenneth Kim
Journal:  PLoS Negl Trop Dis       Date:  2019-02-11

Review 9.  Recently described innate broad spectrum virus inhibitors.

Authors:  S Baron; D Niesel; I P Singh; L McKerlie; J Poast; A Chopra; G Antonelli; F Dianzani; D H Coppenhaver
Journal:  Microb Pathog       Date:  1989-10       Impact factor: 3.738

10.  Anti-Zika virus and anti-Usutu virus activity of human milk and its components.

Authors:  Rachele Francese; Andrea Civra; Manuela Donalisio; Nicola Volpi; Federica Capitani; Stefano Sottemano; Paola Tonetto; Alessandra Coscia; Giulia Maiocco; Guido E Moro; Enrico Bertino; David Lembo
Journal:  PLoS Negl Trop Dis       Date:  2020-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.